✦ LIBER ✦

A NUTRACEUTICAL COMBINATION IMPROVES INSULIN SENSITIVITY IN PATIENTS WITH METABOLIC SYNDROME: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

✍ Scribed by Guido Carlomagno; Flora Affuso; Raffaele Napoli; Valentina Mercurio; Valeria Fazio; Filomena Micillo; Concetta Pirozzi; Antonio Ruvolo; Luigi Saccá; Serafino Fazio

Book ID: 118581356
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 242 KB
Volume: 57
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(11)60546-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral Magnesium supplementation improves

Oral Magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial

✍ F Guerrero-Romero; HE Tamez-Perez; G González-González; AM Salinas-Martínez; J M 📂 Article 📅 2004 🏛 Masson Editeur 🌐 French ⚖ 122 KB

A double blind randomized controlled tri

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome

✍ S. Drouault-Holowacz; S. Bieuvelet; A. Burckel; M. Cazaubiel; X. Dray; P. Martea 📂 Article 📅 2008 🏛 Masson Editeur 🌐 French ⚖ 309 KB

Does pioglitazone improve depression thr

Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression

✍ Kashani, Ladan; Omidvar, Targol; Farazmand, Behnoud; Modabbernia, Amirhossein; R 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 379 KB

Olive leaf extract improves insulin sens

Olive leaf extract improves insulin sensitivity in overweight middle aged males: A randomized, double-blinded, placebo controlled, crossover trial

✍ M. de Bock; J. Derraik; C. Brennan; W. Cutfield 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Rituximab in patients with primary progr

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

✍ Kathleen Hawker; Paul O'Connor; Mark S. Freedman; Peter A. Calabresi; Jack Antel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

## Abstract ## Objective Rituximab, a monoclonal antibody selectively depleting CD20+ B cells, has demonstrated efficacy in reducing disease activity in relapsing‐remitting multiple sclerosis (MS). We evaluated rituximab in adults with primary progressive MS (PPMS) through 96 weeks and safety thro

Continuing metformin when starting insul

Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial

✍ I. F. Douek; S. E. Allen; P. Ewings; E. A. M. Gale; P. J. Bingley; for the Metfo 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB